The upsurge of a healthcare executive professional : John Adlesich

John Adlesich or the climb of a health industry manager expert about healthcare industry trends: COVID-19 has exposed vulnerability at health care organizations across the globe on critical issues, including safety, equipment, data availability, and infrastructure. Early on, it became apparent that “going it alone,” in terms of depending on an organization’s own supply lines and capabilities, wasn’t possible. This led to ad hoc collaborations, with providers, suppliers and non-health-care companies jumping in to deliver resources and capacity to address the crisis. Successful organizations will build upon this mindset, finding ways to close gaps and innovate with partners that bring unique skills to solve problems.

John Adlesich about behavior therapy in 2021: All behavioral therapies share the same reward/consequence paradigm for changing behavior and learning new skills, and they may include some overlap in the way that they are implemented. Despite these similarities, however, children may respond more fully to one approach over another for any number of unknown reasons. If your child is not developing as you expect, or if you believe that he or she may benefit from a combined approach, then pursuing additional therapies is an option to consider. Sharing your ideas and working cooperatively with the professionals who provide services for your child is a good way to explore the efficacy and practical application of other treatment approaches.

John Adlesich on healthcare industry trends: COVID-19 tops the Biden administration’s priorities and will likely do so for the foreseeable future. Vaccine distribution will dominate the first six months of 2021, with federal effort focused on the expansion of testing, contact tracing, and better public health reporting from states and localities up to the CDC and other federal agencies. Data collection and expanded use of data will be critical to the Biden administration’s ongoing COVID-19 response. The administration proposes funding to states and localities for their public health response infrastructure (including registries, reporting, surveillance, and dashboards). The administration also plans to expand the availability of platforms that ensure patient data security and to expand data use rights to enable use and disclosure for research and surveillance. These actions will accelerate research on effective clinical interventions and treatment pathways, expand patient monitoring, and help public health reporting and tracking vaccine distribution. John Adlesich currently works as administrator at Marquis Companies. His latest healthcare industry experience includes positions as executive director at Powerback Rehabilitation Lafayette (Genesis Healthcare) between Aug 2020 – Jan 2021, administrator at Mesa Vista of Boulder between Mar 2019 – Aug 2020, chief executive officer at Sedgwick County Memorial Hospital between Jul 2018 – Feb 2019, interim chief operating officer at Toiyabe Indian Health Project between Mar 2018 – Jun 2018.

John Adlesich believes that 2021 is an important year for the health industry. History gives us many reasons to doubt predictions. In 1916, Charlie Chaplin famously called the motion pictures “a fad.” In 1932, Albert Einstein said that nuclear power was not possible. In 2008, Steve Ballmer predicted the iPhone would be a flop. As these cases show, smart people may see the facts, but not the environmental factors that can shift the entire landscape. This was particularly true in 2020, a year that redefined “normal” and altered our world in ways we are only beginning to understand. In this environment, the hard job of accurately predicting future trends became that much more difficult. When I look back at my own predictions last year, almost none of them played out as I thought due to the pandemic and the complete upending of the national health care agenda. But now 10 months in, the pandemic’s true impact is starting to be understood. For 2021, job number one for the nation will be moving ahead with the largest mass vaccination program in our history, as well as improving our rapid testing capabilities and therapeutic treatments for COVID-19, in order to build our herd immunity and allow us to safely reopen and repair our badly damaged economy. This backdrop will permeate all our decisions this year, and directional trends will largely be influenced by how quickly we make progress in these areas.